Regulation challenge of tissue engineering and regenerative medicine in China

The current regulatory status in the USA, European Union (EU), Japan, and China, associated with the clinical application of tissue engineering and regenerative medicine is presented. It is found that similar regulatory framework has been constructed in the USA and EU, in which risk-based regulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Wang, Chunren, Xi, Tingfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978105/
https://www.ncbi.nlm.nih.gov/pubmed/27574626
http://dx.doi.org/10.4103/2321-3868.118927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978105/
https://www.ncbi.nlm.nih.gov/pubmed/27574626
http://dx.doi.org/10.4103/2321-3868.118927

Ejemplares similares